Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This appears to be a minor, metadata-only update to the page rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-08-31T18:46:22.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, signaling a small patch to the page without altering study information.
    Difference
    0.0%
    Check dated 2026-08-10T10:50:08.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study document revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the document within the study materials.
    Difference
    0.0%
    Check dated 2026-07-27T05:29:40.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.2 to v3.6.3, signaling a minor update to the page’s documentation.
    Difference
    0.0%
    Check dated 2026-07-05T12:30:36.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Version tag updated from v3.6.0 to v3.6.2, indicating a small update to the study record's page metadata. This change does not modify the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:06.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants,' signaling that enrollment is closed. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and changes the revision tag to v3.6.0, while the Intervention/Treatment heading is reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the older v3.5.5 revision label is removed.
    Difference
    0.4%
    Check dated 2026-06-14T00:22:18.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.